GB2085729B - Pharmaceutical composition for oral administration containing coagulation factor viii - Google Patents

Pharmaceutical composition for oral administration containing coagulation factor viii

Info

Publication number
GB2085729B
GB2085729B GB8130122A GB8130122A GB2085729B GB 2085729 B GB2085729 B GB 2085729B GB 8130122 A GB8130122 A GB 8130122A GB 8130122 A GB8130122 A GB 8130122A GB 2085729 B GB2085729 B GB 2085729B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
oral administration
factor viii
coagulation factor
administration containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8130122A
Other languages
English (en)
Other versions
GB2085729A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of GB2085729A publication Critical patent/GB2085729A/en
Application granted granted Critical
Publication of GB2085729B publication Critical patent/GB2085729B/en
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB8130122A 1980-10-17 1981-10-06 Pharmaceutical composition for oral administration containing coagulation factor viii Expired GB2085729B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55144508A JPS5770814A (en) 1980-10-17 1980-10-17 Oral preparation of blood clotting eighth factor

Publications (2)

Publication Number Publication Date
GB2085729A GB2085729A (en) 1982-05-06
GB2085729B true GB2085729B (en) 1984-04-18

Family

ID=15363986

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8130122A Expired GB2085729B (en) 1980-10-17 1981-10-06 Pharmaceutical composition for oral administration containing coagulation factor viii

Country Status (5)

Country Link
JP (1) JPS5770814A (enrdf_load_stackoverflow)
DE (1) DE3141223A1 (enrdf_load_stackoverflow)
ES (1) ES8306323A1 (enrdf_load_stackoverflow)
FR (1) FR2492260A1 (enrdf_load_stackoverflow)
GB (1) GB2085729B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586573B1 (en) 1999-02-22 2003-07-01 Baxter International Inc. Albumin-free Factor VIII formulations

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536392A (en) * 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
IT1164363B (it) * 1983-08-03 1987-04-08 Foscama Biomed Chim Farma Procedimento terapeutico facente uso di liposomi imcorporati fruttosio 1,6 difosfato e procedimento per la preparazione degli stessi
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
FR2581543B1 (fr) * 1985-05-09 1989-07-07 Tressens Dominique Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4115453A1 (de) * 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
FR2706302B1 (fr) * 1993-06-18 1995-08-18 Franche Comte Universite Produit alcalinisant sous forme gastro-résistante.
DE4416180C2 (de) * 1994-05-06 1997-08-14 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats
US6017891A (en) * 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
CH689139A5 (de) * 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
CA2303200A1 (en) * 1997-09-04 1999-03-11 Brian C. Keller Oral liposomal delivery system
AU2009313325B2 (en) 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
DE102009001334B4 (de) 2009-03-04 2017-02-23 Stefan Brosig Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen
CN109316599A (zh) * 2018-08-24 2019-02-12 上海交通大学医学院附属瑞金医院 一种抑肽酶或其突变体、衍生物、类似物或其组成片段的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
NL7900459A (nl) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D Farmaceutisch preparaat en werkwijze ter bereiding daarvan.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586573B1 (en) 1999-02-22 2003-07-01 Baxter International Inc. Albumin-free Factor VIII formulations
US7087723B2 (en) 1999-02-22 2006-08-08 Baxter International Inc. Albumin-free factor VIII formulations
US7247707B2 (en) 1999-02-22 2007-07-24 Baxter International Inc. Albumin-free factor VIII formulations
US8058226B2 (en) 1999-02-22 2011-11-15 Baxter International Inc. Albumin-free factor VIII formulations

Also Published As

Publication number Publication date
JPH03366B2 (enrdf_load_stackoverflow) 1991-01-07
ES506320A0 (es) 1983-05-16
ES8306323A1 (es) 1983-05-16
JPS5770814A (en) 1982-05-01
GB2085729A (en) 1982-05-06
FR2492260A1 (fr) 1982-04-23
DE3141223A1 (de) 1982-06-24
FR2492260B1 (enrdf_load_stackoverflow) 1984-07-27

Similar Documents

Publication Publication Date Title
IL63036A (en) Dosage units for oral administration
GB2085729B (en) Pharmaceutical composition for oral administration containing coagulation factor viii
DE3476633D1 (en) Powdery pharmaceutical composition for nasal administration
IL82911A (en) Pharmaceutical composition comprising omeprazole for oral use
EP0202051A3 (en) Therapeutic compositions for oral administration
IL71967A (en) Drug administration composition
DK163959C (da) Farmaceutisk praeparat til oral indgift indeholdende cimetidin
ZA813465B (en) Pharmaceutical composition
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
GB8319407D0 (en) Medicinal composition containing pirprofen
EP0138420A3 (en) Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives
IL62200A0 (en) Piperidine derivatives,their preparation and pharmaceutical compositions containing them
PH22726A (en) Pharmaceutical composition containing oxicam derivatives
IL95158A0 (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine
GB2088373B (en) Dibenzazepine derivatives and pharmaceutical compositions containing them
GB2074445B (en) Oral pharmaceutical compositions containing cytidine diphospholine
ZA82361B (en) Pharmaceutical composition for treating diseases of the oral cavity
ZA812034B (en) Phrimidyl-quinazolines,process for their preparation pharmaceutical formulations containing these compounds,and their use
ZA817787B (en) Indolinone derivatives,processes for their preparation and pharmaceutical compositions containing these
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
GB2052980B (en) Pharmaceutical composition for oral administration comprising methoxsalen
ATA409082A (de) Buegel zum aufhaengen von rasterdeckenelementen
DE3163490D1 (en) 1,2,4-triazinylthiomethyl-3-cephem sulfoxides, process for their preparation and pharmaceutical compositions containing them
JPS57206615A (en) Medicinal composition containing guanfasin
IL62449A0 (en) Peptides and salts thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee